AK112
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer (NCT07162714) | Zhejiang Cancer Hospital | 2025-10-27 |
| A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC (NCT07086326) | Yang Fan, MD | 2025-07-31 |
| Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs (NCT06766591) | Jiangsu Province Nanjing Brain Hospital | 2025-01-01 |
Track AK112 automatically
Every clearance here is in the API, with alerts when new ones post.